Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular
Pharma
Novo Nordisk rekindles heart failure hopes for semaglutide
After a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for semaglutide are starting to get back on track.
Fraiser Kansteiner
Aug 30, 2024 11:48am
Novo Nordisk's Ozempic cuts dementia risk vs. Merck's Januvia
Jul 12, 2024 10:14am
Novartis tops docs' ranking of heart disease drug makers
May 7, 2024 4:30pm
Novo's Wegovy scores key cardiovascular label expansion
Mar 8, 2024 3:51pm
Novo Nordisk touts cardio outcomes win for Wegovy
Aug 8, 2023 9:49am
Novartis files FDA appeal in bid to block Entresto generics
Sep 16, 2022 11:28am
